Weill Cornell Medical College Sandra & Edward Meyer Cancer Center | Strategic Alliance Partners

Latest from Weill Cornell Medical College Sandra & Edward Meyer Cancer Center


Navigating 2L Treatment Options in CLL

July 30, 2024

Experts on chronic lymphocytic leukemia discuss treatment practices for patients with relapsed/refractory CLL and provide insights on the role for venetoclax in patients who previously received BTK inhibitors.